menu
    • menu

    Company profile for Qiagen

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At the forefront of the molecular biology revolution, more than 500,000 customers worldwide are using QIAGEN Sample & Assay Technologies to achieve breakthroughs based on the building blocks of life – DNA, RNA and proteins. Doctors are diagnosing diseases more precisely and quickly to guide treatment decisions. Scientists are conquering new frontiers in the understanding of life – and translating that knowledge into bet...
    At the forefront of the molecular biology revolution, more than 500,000 customers worldwide are using QIAGEN Sample & Assay Technologies to achieve breakthroughs based on the building blocks of life – DNA, RNA and proteins. Doctors are diagnosing diseases more precisely and quickly to guide treatment decisions. Scientists are conquering new frontiers in the understanding of life – and translating that knowledge into better medications. And experts are safeguarding the public with molecular technologies for human identification, veterinary testing and food safety.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    QiagenGermany Flag
    Country
    Country
    Germany
    Address
    Address
    QIAGEN Strasse 1
    Telephone
    Telephone
    02103-29-12400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.qiagen.com/us
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    QIAGEN Exceeds Q4 2025 Outlook Driven By Growth Pillars
    QIAGEN Exceeds Q4 2025 Outlook Driven By Growth Pillars

    04 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260204085226/en/QIAGEN-Exceeds-Q4-2025-Outlook-Driven-by-Growth-Pillars

    BUSINESSWIRE
    04 Feb 2026
    Share Share
    QIAGEN Unveils Qiasprint Connect System At SLAS 2026
    QIAGEN Unveils Qiasprint Connect System At SLAS 2026

    03 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260203067555/en/QIAGEN-Showcases-QIAsprint-Connect-High-Throughput-Automation-System-for-Labs-Worldwide-at-SLAS-2026

    BUSINESSWIRE
    03 Feb 2026
    Share Share
    QIAGEN Appoints Mark Stevenson To Supervisory Board
    QIAGEN Appoints Mark Stevenson To Supervisory Board

    26 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260126460580/en/QIAGEN-Appoints-Mark-Stevenson-to-Supervisory-Board

    BUSINESSWIRE
    26 Jan 2026
    Share Share
    QIAGEN N.V. To Release Results For Q4 2025 And Hold Webcast
    QIAGEN N.V. To Release Results For Q4 2025 And Hold Webcast

    19 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260119964489/en/QIAGEN-N.V.-to-Release-Results-for-Q4-2025-and-Hold-Webcast

    BUSINESSWIRE
    19 Jan 2026
    Share Share
    QIAGEN Sets 2026 Priorities to Drive Growth Across Five Units
    QIAGEN Sets 2026 Priorities to Drive Growth Across Five Units

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/qiagen-sets-2026-priorities-to-drive-growth-across-five-pillars-toward-achieving-2028-goals-for-soli

    PHARMIWEB
    12 Jan 2026
    Share Share
    QIAGEN Completes $500M Synthetic Share Repurchase
    QIAGEN Completes $500M Synthetic Share Repurchase

    18 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251218217172/en/QIAGEN-Announces-Details-for-Completion-of-Synthetic-Share-Repurchase-of-up-to-Approximately-%24500-Million

    BUSINESSWIRE
    18 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Contact Qiagen and get a quotation

    Qiagen is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of NI-NTA SUPERFLOW bulk offered by Qiagen

    Find a price of QIAGEN NI-NTA AGAROSE bulk offered by Qiagen

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search